Actavis names James D’Arecca chief accounting officer

pharmafile | August 20, 2013 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |   

Actavis has appointed James D’Arecca as the firm’s new chief accounting officer and will report to chief financial officer R. Todd Joyce.

D’Arecca joins Actavis from Bausch & Lomb, where he served in a similar role to his new Actavis position. 

Prior to Bausch & Lomb, he worked for Merck & Co, where he served as executive director and business development controller.  In this role, he was the primary liaison between the controller’s organisation and the business development and corporate licensing functions. 

Advertisement

Prior to joining Merck, D’Arecca was executive director and assistant controller at Schering-Plough. He also spent 13 years with PricewaterhouseCoopers, with an industry focus on pharmaceuticals, medical devices and consumer products.

Related Content

No items found
The Gateway to Local Adoption Series

Latest content